NASDAQ:CDMO
Avid Bioservices Inc. Stock News
$9.12
-0.0800 (-0.87%)
At Close: May 17, 2024
Recap: Avid Bioservices Q3 Earnings
08:27pm, Tuesday, 10'th Mar 2020
Avid Bioservices (NASDAQ:CDMO) reported Q3 results.Quarterly Results • Earnings per share decreased 20% year over year to a loss of $0.06, which missed the estimate by $0.02.• Revenue of $13,585,0
Avid Bioservices Reports Financial Results for Third Quarter Fiscal 2020 and Recent Developments
08:05pm, Tuesday, 10'th Mar 2020
-- Recorded Third Quarter Revenue of $13.6 Million -- -- Signed New Customer and Project Expansion Orders with Current Customers for $20 Million -- -- Adjusting Fiscal 2020.
Avid Bioservices, Inc. to Host Earnings Call
06:30pm, Tuesday, 10'th Mar 2020
NEW YORK, NY / ACCESSWIRE / March 10, 2020 / Avid Bioservices, Inc. (NASDAQ:CDMO) will be discussing their earnings results in their 2020 Third Quarter Earnings call to be held on March 10, 2020 at 4:
DexCom CEO: Things continue to go very well at the company DXCM
11:44am, Tuesday, 10'th Mar 2020
DexCom CEO: Things continue to go very well at the company DXCM
Fly Intel: After Hours Movers HEAR;CLDR;APTO;DXC;CDMO;CLNE;VSLR;KFY;CTRE;HLT
11:37am, Tuesday, 10'th Mar 2020
Fly Intel: After Hours Movers HEAR CLDR APTO DXC CDMO CLNE VSLR KFY CTRE HLT
Kosmos CEO buys 300K shares of common stock KOS
11:27am, Tuesday, 10'th Mar 2020
Kosmos CEO buys 300K shares of common stock KOS
GAITHERSBURG, Md., March 10, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that it has entered into an agreement with...
Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock
09:05pm, Wednesday, 04'th Mar 2020
TUSTIN, Calif., March 04, 2020 -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working.
Avid Bioservices to Report Financial Results for Third Quarter of Fiscal Year 2020 After Market Close on March 10, 2020
09:05pm, Tuesday, 03'rd Mar 2020
TUSTIN, Calif., March 03, 2020 -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working.
When Will Avid Bioservices, Inc. (NASDAQ:CDMO) Become Profitable?
11:51am, Monday, 17'th Feb 2020
Avid Bioservices, Inc.'s (NASDAQ:CDMO): Avid Bioservices, Inc., a contract development and manufacturing organization...
20 Biopharma Stocks for Huge Upside Potential in 2020
12:05pm, Saturday, 11'th Jan 2020
Here are 20 biotechnology and pharmaceutical stocks that have been given big analyst upside targets for 2020.
Avid Bioservices Appoints Timothy Compton as Chief Commercial Officer
01:05pm, Wednesday, 08'th Jan 2020
Avid Bioservices, Inc. (CDMO) (CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manuf
Can You Imagine How Chuffed Avid Bioservices's (NASDAQ:CDMO) Shareholders Feel About Its 252% Share Price Gain?
12:03pm, Friday, 03'rd Jan 2020
The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...
Should You Buy Avid Bioservices, Inc. (CDMO)?
12:18pm, Monday, 16'th Dec 2019
We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November. Among them, Facebook and Microsoft ranked among the top 3 picks a
Avid Bioservices (CDMO) Reports Q2 Loss, Tops Revenue Estimates
10:25pm, Monday, 09'th Dec 2019
Avid Bioservices (CDMO) delivered earnings and revenue surprises of 25.00% and 23.74%, respectively, for the quarter ended October 2019. Do the numbers hold clues to what lies ahead for the stock?
